At present this explicitly does not include a "lockdown such as we have seen in countries abroad."
I would recommend you not make plans which are contingent on that state of affairs continuing.
"What's the biggest change we're likely to see?"
Every public and private org in Japan will have a conversation tomorrow, and in lamentably many cases for *the first time* tomorrow, on what their coronavirus strategy should be. Some will act; some will start planning to act.
"Every" is a bit of an overstatement for effect here, but as of tomorrow it's hard to imagine e.g. a large corporation or city not having several hundred people working on this issue.
That is, unfortunately, not terribly hard to imagine as of last week or even this morning.
The press conference includes the first time I've heard the acknowledgement from on high (in Japanese) that asymptomatic people can be infectious, which is one of the most important facts for the public health response and which will likely surprise a lot of decisionmakers.
Request from the government to avoid moving from Tokyo/Osaka/etc ("as we've seen abroad during lockdowns") to regions of Japan because a) risk in Tokyo/Osaka/etc "if living life as normal" is low and b) high at-risk population in the regions.
(Both quotes approximate.)
Government clarifies that while compliance with government requests to avoid e.g. operating businesses considered at high risk to spread coronavirus is at the discretion of the business owner, that request could be made directly, by police, in the course of their official duties.
I will note for the benefit of Japanese speakers searching the transcript that the word 職務質問 was used by the questioner, and think your friendly neighborhood legal professional can explain why that is an important word choice.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Listening to @_rossry ‘s new podcast about drug development and the first episode about operational competence issues in clinical trials is giving me flashbacks.
Ross and Meri discuss how clinical research organizations, who are essentially GCs sitting between pharma labs and sites which actually have clinical staff that can see patients, often are other than competent at meat and potatoes execution.
Interesting article about falling backwards into founding a non-profit and then doing policy advocacy work, which had a number of points which resonated with me:
There is another paragraph about feeling turbocharged imposter syndrome when talking to subject matter experts and then realizing they’ve spent 0.01% of their career on *exactly* your new problem and so you understood it better than they do as of about day four or so.
In today's very surprising example of things an LLM could be good at:
I had a print failure while running a resin print in the wee hours of the morning.
Debugging these is a bit maddening. They arise from a combination of software, math, chemistry, and unpredictable chaos.
They're also very underdocumented. (In what is surely a first in the history of manufacturing.)
The community is spread between various Facebook groups and Discords, and writes little down formally. Most recorded lore is in YouTube videos, and aimed at low-skill enthusiasts.
And when a print failure happens, all you have to go on is the symptom to figure out where to start investigating. You'll see e.g. a sheer within a print or a melted rump instead of a dragon or, as happened with me yesterday, a build plate wrenched to 30 degrees off level.
There are Sorts within the Sort, all the way down.
(Incidentally, if you have an academically disinclined young family member who nonetheless is not a layabout, GC is potentially a good career for them.
Most people get into it after a stint in trades or real estate, but that isn’t strictly required.)
I don’t have anything novel to contribute on the substance of but have to again comment, pace Situational Awareness that I think kicked this trend off, that single-essay microdomains with a bit of design, a bit of JS, and perhaps a downloadable PDF are…ai-2027.com
… a really interesting form factor for policy arguments (or other ideas) designed to spread.
Back in the day, “I paid $15 to FedEx to put this letter in your hands” was one powerful way to sort oneself above the noise at a decisionmaker’s physical inbox, and “I paid $8.95 for a domain name” has a similar function to elevate things which are morally similar to blog posts.
This week on Complex Systems, a continued discussion of credit card rewards, interchange, and what I believe is a persistent misconception about how society should want justice done via payments systems.
It ends with the following, which the team took the liberty of putting into a short clip. (Sound on if you like hearing my voice, but video is subtitled.)
Last week the Atlantic published an opinion piece which argues that the poor are subsidizing the rich's receipt of credit card rewards. This view has wide currency among certain advocates and among opinion writers.
It is not true.
Credit card rewards are actually funded by interchange, a cost which is ultimately paid by card-accepting businesses for a combination of services they get from the payments industry.
Rewards have a few equilibria globally; the U.S. is in a high rewards, high interchange one.